© 2000 by European Society of Cardiology
Copyright © 2000, European Society of Cardiology
eNOS inhibition of proliferation: a role for p21Sdi1/Cip1/Waf1 and p27kip1
Cardiovascular Research Group, Clinical Sciences Centre, Northern General Hospital, Sheffield S5 7AU, UK
* Corresponding author. Tel.: +44-114-271-4973; fax: +44-114-261-9587 c.holt@sheffield.ac.uk
Received 14 June 2000; accepted 26 June 2000
| The first 10% of the full text of this article appears below. |
See article by Sato et al. [12] (pages 697–706) in this issue.
It is over 10 years since NO donors were shown to reduce proliferation of vascular smooth muscle cells (VSMC) [1]. More recently, increase in vessel wall thickness and hyperplasia were shown to occur following ligation of the carotid artery in NO synthase (eNOS) knockout mice suggesting NO to be a negative regulator of vascular cell proliferation [2]. Due to the short half-life and limited solubility of NO, NO synthase (NOS) is often used as a way of enhancing local NO